Key Financial
Guidance 2022

FY2022 Revenue US$270 - $280m
FY2022 Adjusted EBITDA
US$47 - $53m
Cash & Receivables US$230m
Laboratory and rapid
at-home tests
26 million+

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases